Where Photobiomodulation Comes From

The story begins in the late 1960s, shortly after lasers became available for medical research. In Hungary, physician and researcher Endre Mester was studying how low-power laser light interacted with living tissue.

At the time, there was uncertainty about whether laser exposure could be harmful. To explore this, Mester conducted experiments on laboratory mice, exposing shaved areas of skin to very low-energy red light. What he observed was unexpected.

The light did not damage tissue. Instead, wounds healed faster, and hair grew back more quickly in the treated areas.

What began as a safety question led to an unexpected observation, light did not harm tissue, it appeared to support healing.

This was the first clear indication that low-intensity red light could stimulate biological processes rather than disrupt them. These findings laid the foundation for what would later be called low-level laser therapy.

In the years that followed, researchers across Europe continued to investigate why these effects occurred. Gradually, it became clear that the benefits were not caused by heat or surface irritation.

Instead, specific wavelengths of red and near-infrared light were found to interact with cells at a deeper level, particularly within the mitochondria - the structures responsible for cellular energy production. Light absorption at these wavelengths influences how efficiently cells generate energy and regulate repair processes.

This shift in understanding led to a broader concept: light was not acting as a physical treatment, but as a biological signal. The term photobiomodulation was introduced to better reflect this mechanism.

Decades later, space agencies began exploring red light for use in space environments, where wound healing and tissue maintenance can be impaired. These programs helped accelerate the development of LED-based systems, which offered safer, lighter, and more practical alternatives to lasers.

NASA did not discover photobiomodulation, but its research played an important role in proving that LEDs, not just lasers, could produce meaningful biological effects when used correctly.

As the field matured, photobiomodulation research branched into two main directions.

One focused on general applications such as wound healing, pain relief, inflammation, and skin health.

The other explicitly focused on hair follicles and patterned hair loss. In this branch, controlled studies examined how red and near-infrared light could support hair follicle activity by improving cellular energy availability and local biological conditions.

It is this second path, targeted, follicle-focused photobiomodulation, that underpins modern light-based treatments for hair thinning and androgenetic alopecia.

Today, photobiomodulation for hair loss is best understood not as a trend or cosmetic shortcut, but as the result of decades of biological research. Its effectiveness depends on precise wavelengths, appropriate dosing, full scalp coverage, and consistent use over time.

The science is not new. The challenge lies in how faithfully it is applied.

What continues to evolve is how accurately science is translated into real-world devices.

For a modern explanation of how photobiomodulation is used in LED hair growth caps, see our complete guide.